These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17639166)

  • 21. Risk factors and outcomes for bloodstream infections with extended-spectrum beta -lactamase-producing Klebsiella pneumoniae ; Findings of the nosocomial surveillance system in Hungary.
    Szilágyi E; Füzi M; Böröcz K; Kurcz A; Tóth A; Nagy K
    Acta Microbiol Immunol Hung; 2009 Sep; 56(3):251-62. PubMed ID: 19789140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors and molecular epidemiology of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Xiamen, China.
    Deng J; Li YT; Shen X; Yu YW; Lin HL; Zhao QF; Yang TC; Li SL; Niu JJ
    J Glob Antimicrob Resist; 2017 Dec; 11():23-27. PubMed ID: 28842361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of blood stream infections with extended spectrum beta-lactamase-producing and non-producing Klebsiella pneumoniae in pediatric patients.
    Tanır Basaranoglu S; Ozsurekci Y; Aykac K; Karadag Oncel E; Bıcakcigil A; Sancak B; Cengiz AB; Kara A; Ceyhan M
    Ital J Pediatr; 2017 Sep; 43(1):79. PubMed ID: 28899399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Liu HC; Hung YP; Lin HJ; Liu HC; Lee JC; Wu YH; Li CW; Li MC; Ko WC
    J Microbiol Immunol Infect; 2016 Aug; 49(4):584-90. PubMed ID: 26692184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study.
    Demirdag K; Hosoglu S
    J Infect Dev Ctries; 2010 Nov; 4(11):717-22. PubMed ID: 21252449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic use and the risk of carbapenem-resistant extended-spectrum-{beta}-lactamase-producing Klebsiella pneumoniae infection in hospitalized patients: results of a double case-control study.
    Kritsotakis EI; Tsioutis C; Roumbelaki M; Christidou A; Gikas A
    J Antimicrob Chemother; 2011 Jun; 66(6):1383-91. PubMed ID: 21454344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Extended-spectrum β-lactamase producing bacilli in a paediatric hospital].
    Dias A; Oliveira G; Oliveira H; Marques M; Rodrigues F
    Acta Med Port; 2011 Dec; 24 Suppl 2():197-206. PubMed ID: 22849904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum beta-lactamase.
    Peña C; Pujol M; Ardanuy C; Ricart A; Pallarés R; Liñares J; Ariza J; Gudiol F
    J Hosp Infect; 2001 Jan; 47(1):53-9. PubMed ID: 11161899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extended-spectrum beta-lactamase-producing Klebsiella pneumoniae hospital acquired bacteremia. Risk factors and clinical outcome.
    Panhotra BR; Saxena AK; Al-Ghamdi AM
    Saudi Med J; 2004 Dec; 25(12):1871-6. PubMed ID: 15711657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae isolated in a rural hospital.
    Basak S; Mallick SK; Bose S
    J Indian Med Assoc; 2009 Dec; 107(12):855-8. PubMed ID: 20509468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for hospital-acquired bloodstream infections caused by extended-spectrum β-lactamase Klebsiella pneumoniae among cancer patients.
    Li D; Chen Y; Zhang W; Zheng S; Zhang Q; Bai C; Zhang P
    Ir J Med Sci; 2014 Sep; 183(3):463-9. PubMed ID: 24293294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
    Han SB; Jung SW; Bae EY; Lee JW; Lee DG; Chung NG; Jeong DC; Cho B; Kang JH; Kim HK; Park YJ
    Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prompt control of an outbreak caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a neonatal intensive care unit.
    Cantey JB; Sreeramoju P; Jaleel M; Treviño S; Gander R; Hynan LS; Hill J; Brown C; Chung W; Siegel JD; Sánchez PJ
    J Pediatr; 2013 Sep; 163(3):672-9.e1-3. PubMed ID: 23582136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of an outbreak due to extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in a pediatric intensive care unit transplant population.
    Rebuck JA; Olsen KM; Fey PD; Langnas AN; Rupp ME
    Clin Infect Dis; 2000 Dec; 31(6):1368-72. PubMed ID: 11096004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extended spectrum beta-lactamases in Escherichia coli & Klebsiella pneumoniae & associated risk factors.
    Goyal A; Prasad KN; Prasad A; Gupta S; Ghoshal U; Ayyagari A
    Indian J Med Res; 2009 Jun; 129(6):695-700. PubMed ID: 19692752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What may be lurking in the hospital undergrowth? Inapparent cross-transmission of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
    Skally M; Duffy F; Burns K; Doyle D; Foley S; Thomas T; Collins C; Smyth E; Turton J; Humphreys H
    J Hosp Infect; 2014 Nov; 88(3):156-61. PubMed ID: 25280879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Extended Spectrum Beta-Lactamase Producing Klebsiella Pneumoniae Isolated From Urinary Tract Infected Patients.
    Chaudhary P; Bhandari D; Thapa K; Thapa P; Shrestha D; Chaudhary HK; Shrestha A; Parajuli H; Gupta BP
    J Nepal Health Res Counc; 2016 May; 14(33):111-115. PubMed ID: 27885293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment with fluoroquinolones or with beta-lactam-beta-lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum-beta-lactamase-producing Klebsiella species in hospitalized patients.
    Wener KM; Schechner V; Gold HS; Wright SB; Carmeli Y
    Antimicrob Agents Chemother; 2010 May; 54(5):2010-6. PubMed ID: 20211888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for acquisition of CTX-M-15 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae during an outbreak in a neonatal intensive care unit in Norway.
    Rettedal S; Høyland Löhr I; Natås O; Sundsfjord A; Øymar K
    Scand J Infect Dis; 2013 Jan; 45(1):54-8. PubMed ID: 22991960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and molecular epidemiology of healthcare-associated infections due to extended-spectrum beta-lactamase (ESBL)-producing strains of Escherichia coli and Klebsiella pneumoniae that harbor multiple ESBL genes.
    Apisarnthanarak A; Kiratisin P; Mundy LM
    Infect Control Hosp Epidemiol; 2008 Nov; 29(11):1026-34. PubMed ID: 18947321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.